Related Experiment Videos
Elastic fiber abnormalities associated with a leaflet perforation in floppy mitral valve
K Tamura1, Y Fukuda, V J Ferrans
1Department of Pathology, Nippon Medical School, Tokyo, Japan.
The Journal of Heart Valve Disease
|August 11, 1998
Summary
Researchers describe unique elastic fiber changes in a perforated floppy mitral valve. These abnormalities, resembling those seen with lysyl oxidase inhibition, may explain the valve perforation.
Area of Science:
- Cardiovascular Pathology
- Connective Tissue Biology
- Biochemistry
Background:
- Floppy mitral valve (FMV) is a common valvular heart disease, often associated with myxomatous degeneration.
- The pathogenesis of severe FMV, particularly perforation, remains incompletely understood.
- This study investigates the ultrastructural changes in elastic fibers within a perforated mitral valve.
Observation:
- A 68-year-old male patient presented with a perforated floppy mitral valve without a history of infective endocarditis or stigmata of connective tissue disorders (Marfan, Ehlers-Danlos syndromes).
- Ultrastructural examination revealed unique, round expansions of amorphous components within elastic fibers at the perforation site.
- These expanded areas lacked associated microfibrils, and microfibril aggregations without amorphous components were also noted.
Findings:
- The observed elastic fiber abnormalities, characterized by expanded amorphous components and microfibril alterations, are distinct from typical myxomatous degeneration.
- These ultrastructural features closely mimic those reported in animal models treated with beta-aminopropionitrile (BAPN), a lysyl oxidase inhibitor.
- Lysyl oxidase plays a critical role in elastin cross-linking; its inhibition leads to impaired elastic fiber integrity.
Implications:
- The findings suggest a potential role for impaired elastin cross-linking or altered extracellular matrix remodeling in the pathogenesis of mitral valve perforation.
- This cellular mechanism may represent a distinct pathway contributing to floppy mitral valve disease progression.
- Further research into lysyl oxidase activity and its inhibitors could offer novel therapeutic targets for valvular heart disease.